GJB2 and deafness: Bi-allelic GJB2 mutations were reported in 19.1% of patients with non-syndromic deafness, followed by bi-allelic SLC26A4 mutations in 12.1% and the mitochondrial MT-RNR1 mutations in 1.6% [2–4].